Diabetes drug cuts blood sugar, weightSanofi's candidate drug Lyxumia, or lixisenatide, added to basal insulin, {significantly|considerably} reduced blood sugar levels in type 2 diabetes patients and {also|additionally|conjointly} led to a loss in weight, {data|knowledge|information} {published|revealed|printed} on Tuesday showed.
Lyxumia belongs to the GLP-1 {class|category} {of drugs|of medicine|of medication} that stimulate insulin {release|unharness|unleash} when glucose levels become too high. {it is|it's} not {yet|however|nevertheless|nonetheless} approved for sale anywhere {in the|within the} world.
The French drugmaker licensed Lyxumia from Zealand Pharma {and the|and therefore the|and also the} so-called GLP-1 treatment is seen as a {possible|potential|attainable|doable} blockbuster {which|that} {could|might|may} {help|facilitate} Sanofi reach its goal of {becoming|turning into|changing into} the world's {top|prime|high} diabetes treatment company.
Read more Diabetes drug cuts blood sugar, weight
0 komentar:
Posting Komentar